Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Glioblastoma 4Gliosarcoma 2Brain Neoplasms 2Sarcoma, Kaposi 1Sarcoma 1Recurrence 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Congenital Abnormalities 1Astrocytoma 1AIDS-related Kaposi sarcoma 1

Interventions

Biopsy 2emvododstat 1efineptakin alfa 1X-Rays 1Specimen Handling 1Sorafenib 1SUB1 protein, human 1Rituximab 1Polymerase Chain Reaction 1Nivolumab 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Immunohistochemistry 1Gene Expression Profiling 1Everolimus 1Daunorubicin 1Cilengitide 1CTLA-4 Antigen 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Kaposi × Cilengitide × Clear all
NCT00006222 2013-06-03

EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 1 Terminated
30 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡